| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 31 |
| 1 | FLUOROURACIL | 27 |
| 2 | FLUOROURACIL CREAM, 0.5% | 27 |
| 3 | IBUPFROFEN | 9 |
| 4 | IBUPROFEN | 9 |
| 5 | IBUPROFEN 200 MG | 9 |
| 6 | IBUPROFEN 200MG | 9 |
| 7 | IBUPROFEN CAPSULE | 9 |
| 8 | IBUPROFEN CAPSULES 200 MG | 9 |
| 9 | IBUPROFEN ORAL | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PORFIMER SODIUM | 6 | 0.0176 |
| 1 | BACILLUS CALMETTE-GUERIN | 1 | 0.0006 |
| 2 | CISPLATIN | 31 | 0.0004 |
| 3 | FLUOROURACIL CREAM, 0.5% | 27 | 0.0003 |
| 4 | SEVELAMER CARBONATE | 4 | 0.0003 |
| 5 | FLUOROURACIL | 27 | 0.0003 |
| 6 | VINORELBINE | 2 | 0.0003 |
| 7 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 9 | DAPTOMYCIN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 1 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 2 | Platinum-based Drug [EPC] | 43 | 0.0002 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 30 | 0.0001 |
| 4 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 6 | Microtubule Inhibitor [EPC] | 14 | 0.0001 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 | 0.0000 |
| 8 | Ester Local Anesthetic [EPC] | 2 | 0.0000 |
| 9 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |